Lifecare AS
OSE:LIFE
Intrinsic Value
Lifecare AS engages in the research, testing, and development of medical sensors for health monitoring. [ Read More ]
The intrinsic value of one LIFE stock under the Base Case scenario is 2.05 NOK. Compared to the current market price of 2.7 NOK, Lifecare AS is Overvalued by 24%.
Valuation Backtest
Lifecare AS
Run backtest to discover the historical profit from buying and selling LIFE stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Lifecare AS
Current Assets | 34m |
Cash & Short-Term Investments | 34.8m |
Receivables | -814k |
Other Current Assets | 1k |
Non-Current Assets | 19.5m |
PP&E | 6.5m |
Intangibles | 13.1m |
Current Liabilities | 3.1m |
Accounts Payable | 237k |
Other Current Liabilities | 2.9m |
Non-Current Liabilities | 9.2m |
Long-Term Debt | 7.6m |
Other Non-Current Liabilities | 1.6m |
Earnings Waterfall
Lifecare AS
Revenue
|
17.3m
NOK
|
Operating Expenses
|
-41.4m
NOK
|
Operating Income
|
-24.1m
NOK
|
Other Expenses
|
-747k
NOK
|
Net Income
|
-24.9m
NOK
|
Free Cash Flow Analysis
Lifecare AS
LIFE Profitability Score
Profitability Due Diligence
Lifecare AS's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
Score
Lifecare AS's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
LIFE Solvency Score
Solvency Due Diligence
Lifecare AS's solvency score is 86/100. The higher the solvency score, the more solvent the company is.
Score
Lifecare AS's solvency score is 86/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LIFE Price Targets Summary
Lifecare AS
According to Wall Street analysts, the average 1-year price target for LIFE is 4.59 NOK with a low forecast of 4.55 NOK and a high forecast of 4.73 NOK.
Shareholder Return
LIFE Price
Lifecare AS
Average Annual Return | 18.22% |
Standard Deviation of Annual Returns | 69.09% |
Max Drawdown | -84% |
Market Capitalization | 364.1m NOK |
Shares Outstanding | 134 866 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Lifecare AS engages in the research, testing, and development of medical sensors for health monitoring. The company is headquartered in Bergen, Hordaland. The company went IPO on 2018-07-10. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
Contact
IPO
Employees
Officers
The intrinsic value of one LIFE stock under the Base Case scenario is 2.05 NOK.
Compared to the current market price of 2.7 NOK, Lifecare AS is Overvalued by 24%.